Annals of Lung Cancer

 ISSN: 2643-5713

Annals of Lung Cancer

Home / Browse Journals & Books /  Annals of Lung Cancer  / Archive /  Volume 4, Issue 1

Table of Content: Volume 4, Issue 1

  Select All | |

Research Article Pages 94-95

Pembrolizumab in Non-Small Cell Lung Cancer: The Role of Restricted Mean Survival Time in Estimating The Long-Term Survival Benefit

Authors: Andrea Messori PharmD, Marco Chiumente PharmD and Daniele Mengato PharmD

Abstract: In comparison with the median, the restricted mean survival time (RMST) has a specific advantage because it examines the whole survival curve (like the hazard ratio) and expresses the survival outcomes using time as unit of measurement (like medians). More importantly, the RMST captures the presence of a long-term survival plateau indicating a better prognosis. Previous experiences on the application of RMST are mostly focused on oncology but other fields are being investigated as well. An original model-independent method of calculation, drawn from the field of pharmacokinetics, has markedly simplified the otherwise complex estimation of RMST

| | |

Publish with Scholars.Direct

Track your Manuscript Status

(Please write to in case of any technical error)
porn video
porn sex